Training program for developing new cancer treatments
Official title: Experimental Therapeutics in Cancer Training Program
Funded at Oregon Health & Science University · NIH-11013740 · Data updated 2026-11-12
This program is designed to help researchers learn how to turn new scientific ideas into better cancer treatments, giving them hands-on experience at the Knight Cancer Institute while working closely with experts in both basic and clinical research.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | January 15, 2025 |
| Project end | December 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $178,541 |
| NIH project number | 1T32CA285265-01A1 |
| Project ID | NIH-11013740 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are postdoctoral fellows with a PhD or MD who are interested in oncological drug development.
✕Less likely to help
Patients who are not involved in research training or do not have a background in cancer therapeutics may not benefit from this program.
What this research studies
This program focuses on training both basic and clinical researchers in the development of innovative cancer therapeutics. It offers a two-year immersive postdoctoral experience at the Knight Cancer Institute, where participants will learn to translate scientific discoveries into effective cancer treatments. The program emphasizes collaboration between basic and clinical science, providing mentorship from experienced faculty in both fields. By fostering a multidisciplinary approach, the training aims to accelerate the development of new therapies for cancer patients.
Why it matters
Potential benefit: If successful, this research could lead to the development of groundbreaking cancer treatments that improve patient outcomes.
How similar studies have gone: Similar training programs have successfully produced advancements in cancer treatment, indicating a strong potential for success in this initiative.
Where this research is happening
-
Oregon Health & Science University
Portland, United States Active
Researchers
- Principal investigator: Kummar, Shivaani — Oregon Health & Science University
- Study coordinator: Kummar, Shivaani
Related research
Other NIH-funded projects on the same topics.
-
Understanding how a protein affects nerve cell movement in Alzheimer's disease
This study is looking at how a protein called APP affects the growth and movement of nerve cells, which is important for understanding Alzheimer's disease, and it aims to find out how problems with this protein might lead to nerve cell damage.
-
Understanding how the bone marrow environment drives AML resistance
A large NIH-funded project at Oregon Health & Science University is studying how the body’s own cell surroundings help acute myeloid leukemia become resistant to treatment, with potential paths to better therapies for patients.
-
Improving Safety at Work with a Low-Resource mHealth Program in Malaysia (and beyond)
A low-cost mobile health program to improve safety culture in Malaysian workplaces, with plans to adapt the approach for U.S. workers in high-risk industries.
-
Oregon Healthy Workplace Initiative for Better Health
A multi-site effort aims to improve the health and safety of workers by coordinating research, tools, and interventions across workplaces.
-
Understanding how AML cells become resistant to therapy over time
This project looks at why acute myeloid leukemia stops responding to treatment and how to design better drug combinations to prevent relapse.
-
Mechanisms and Countermeasures for Ultra-Potent Synthetic Opioid Overdose
A small, focused NIH grant aims to understand why ultra-potent synthetic opioids cause severe overdose and to explore potential countermeasures to keep people safe.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.